Clinical Trial Update: Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy and safety of norketotifen in adults with allergic rhinitis and rhinoconjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• Norketotifen (norketotifen)

Snippet

Sponsor: Emergo Therapeutics, Inc. | Conditions: Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED